Published on
January 30, 2025
- 04:30 GMT
Release Therapeutics Announces New CEO to Advance Groundbreaking Treatment for Brain Disorders
Dr. Julien Grogg will Lead the Company's Transition to Clinical Development Building on Promising Primate Study GENEVA, SWITZERLAND, January 30, 2025 /EINPresswire.com/ -- Release Therapeutics (‘RTx’ or ‘the Company’), a privately held, Swiss …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...
